Back

Early onset motor defects and electrographic seizures in a mouse model of the most common mutation in EEF1A2 related neurodevelopmental disorder, E122K

Marshall, G. F.; Fasol, M.; Davies, F. C. J.; Le Seelleur, M.; Alvarez, A. F.; Bennett-Ness, C.; Gonzalez Sulser, A.; Abbott, C. M.

2023-09-07 neuroscience
10.1101/2023.09.07.556644 bioRxiv
Show abstract

De novo heterozygous missense mutations in EEF1A2, encoding neuromuscular translation-elongation factor eEF1A2, are associated with developmental and epileptic encephalopathies. We used CRISPR/ Cas9 to recapitulate the most common mutation, E122K, in mice. Although E122K/+ mice were not observed to have convulsive seizures, they exhibit frequent electrographic seizures and EEG abnormalities, transient early motor delays and growth defects. Both E122K homozygotes and Eef1a2-null mice develop progressive motor abnormalities phenotypes, with homozygotes reaching humane endpoints by P31. Surprisingly, E122K homozygotes did not exhibit the progressive spinal neurodegeneration which drives the null phenotype. The E122K protein is relatively stable in neurons yet highly unstable in skeletal myocytes, suggesting that the E122K/E122K phenotype is instead driven by loss-of-function in muscle. Importantly, E122K homozygotes developed abnormalities far earlier than nulls, suggesting a toxic gain-of-function. This novel mouse model represents the first animal model of an EEF1A2 missense mutation with face-valid phenotypes and has provided mechanistic insights needed to inform rational treatment design.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.